Press release
Soaring Demand Set to Propel Glycomic Therapeutics Market to $359.62 Billion by 2029
Glycomic Therapeutics Market
What Is the Expected CAGR for the Glycomic Therapeutics Market Through 2025?
The glycomic therapeutics market has experienced swift expansion lately, projected to escalate from a valuation of $164.71 billion in 2024 up to $189.51 billion by 2025, reflecting a compound annual growth rate (CAGR) of 15.1%; this historical surge is supported by heightened recognition of the importance of glycans, an uptick in prevalent long-term illnesses, advancements in creating medicines for infrequent disorders, along with greater cooperative efforts within glycomics investigations.
What's the Projected Size of the Global Glycomic Therapeutics Market by 2029?
Anticipated to expand swiftly over the ensuing years, the overall glycomic therapeutics market is projected to reach a valuation of $359.62 billion by the year 2029, achieving a compound annual growth rate (CAGR) amounting to 17.4%. This upward trajectory throughout the prediction window is fundamentally driven by several factors, such as the deepening comprehension of glycan biology, the increased adoption of precision medicine methodologies, a growing focus on immunotherapy strategies, augmented financial support directed towards research on infrequent ailments, and the identification of novel glycan biomarkers; concurrently, key developments shaping this period encompass the broadening utility of glycomics within oncology, the practice of glycoengineering to improve therapeutic protein efficacy, the integration of glycomics into immuno-oncology studies, the application of glycomics to address rare and inherent genetic conditions, alongside evolving regulatory viewpoints concerning therapeutic agents derived from glycomics.
View the full report here:
https://www.thebusinessresearchcompany.com/report/glycomic-therapeutics-global-market-report
Top Growth Drivers in the Glycomic Therapeutics Industry: What's Accelerating the Market?
The rising incidence of diabetes is anticipated to fuel expansion within the glycomic therapeutics sector. As a long-term ailment impacting the body's capacity to manage blood sugar concentrations, diabetes involves observable shifts in glycans, which in turn can foster insulin resistance and various metabolic dysfunctions, thus making specific glycan profiles useful for identifying the condition, forecasting its advancement, and tracking therapeutic outcomes. To illustrate this trend, data released in March 2022 by the IDF Diabetes Atlas, a key international source for detailed diabetes statistics, estimated that the worldwide patient count for diabetes is set to climb from 643 million in the year 2030 up to 783 million by 2045, representing an escalation of 140 million instances, consequently pushing forward the market growth for glycomic treatments.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11894&type=smp
What Trends Will Shape the Glycomic Therapeutics Market Through 2029 and Beyond?
A significant current trending direction within the glycomic therapeutics market centers on novel product development. Leading firms within this therapeutic area are concentrating efforts on creating fresh technological advancements and inventive approaches to solidify their marketplace standing. As an illustration, in April of 2022, Glenmark Pharmaceuticals Limited, a pharmaceutical enterprise situated in India, introduced an innovative fixed-dose combination (FDC) formulation aimed at enhancing glycemic regulation and lessening insulin resistance for individuals suffering from type 2 diabetes; this new therapy integrates the DPP4 inhibitor Teneligliptin alongside Pioglitazone as part of its advanced therapeutic offerings.
What Are the Main Segments in the Glycomic Therapeutics Market?
The glycomic therapeuticsmarket covered in this report is segmented -
1) By Class: Isolated; Synthetic
2) By Structures: Glycoproteins; Targeting Sialic Acid; Proteoglycans; Targeting Glycosaminoglycans; Glycosylphosphatidylinositol (GPI)-Anchored Proteins And Heparin Based Glycans; Targeting Glycosphingolipids; Other Structures
3) By Mode Of Action: Inhibits Neuraminidase; Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate; Erythropoietin And Enzyme Replacement Therapy (ERT); Tissue Plasminogen Activator; Inhibits Glucosylceramide Synthase; Interleukin 1, 2 And 3; Beta And Gamma Interferons; Other Mode Of Action
4) By Indications: Thrombosis And Chemoprophylaxis; Anemia; Anti-Adhesive And Anti-Inflammatory; Cataracts; Gaucher's Disease; Mps-1 And IV; Cancer; Alzheimer's Disease; Influenza Type A And B; Other Indications
Subsegments:
1) By Isolated: Natural Glycans; Glycan Derivatives; Glycoproteins
2) By Synthetic: Chemically Synthesized Glycans; Recombinant Glycans; Glycopeptides
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=11894&type=smp
Which Top Companies are Driving Growth in the Glycomic Therapeutics Market?
Major companies operating in the glycomic therapeutics market include F Hoffmann-La Roche Ltd., Bayer AG, Sanofi SA, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, Merck KGaA, ICON plc, Agilent Technologies Inc., AMS Bio, Shimadzu Corporation, Waters Corporation, Bruker Corporation, BioMarin Pharmaceutical Inc., Bio Techne Corp., Promega Corporation, Halozyme Therapeutics Inc., Takara Bio Inc., Vector Laboratories, New England Biolabs Inc., Protalix Biotherapeutics Inc., Genovis AB, Ray Biotech Life Inc., IEC Group, Ludger Ltd, Z Biotech LLC, Alzheon Inc., GlycoMar Limited
Which Regions Will Dominate the Glycomic Therapeutics Market Through 2029?
North America was the largest region in the glycomic therapeutics in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the glycomic therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11894
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Soaring Demand Set to Propel Glycomic Therapeutics Market to $359.62 Billion by 2029 here
News-ID: 4270371 • Views: …
More Releases from The Business Research Company
Segment Analysis And Key Growth Categories In The Disc Sterilizer Steam Market
The disc sterilizer steam market is poised for notable expansion in the coming years, driven by advances in healthcare and biotechnology sectors. With growing emphasis on infection control and medical safety, this industry is evolving rapidly, supported by technological innovations and increasing healthcare investments around the world. Below is an in-depth look at the current market size, leading players, emerging trends, and segmentation details shaping this market's future trajectory.
Projected Market…
New Growth Trends Accelerating Expansion In The Dental Practice Revenue Analytic …
The dental practice revenue analytics market is poised for significant advancement as dental care providers increasingly embrace technological solutions to enhance their financial and operational performance. With the integration of innovative analytics tools, the sector is set to transform how dental practices manage revenue and patient outcomes. Let's delve into the market size projections, key players, notable trends, and segment details shaping this evolving industry.
Projected Growth and Market Size of…
Segmentation Overview, Market Dynamics, And Competitive Positioning In The DC Wa …
The market for DC wallbox chargers is set for a remarkable expansion as electric vehicles (EVs) continue to gain popularity and demand for efficient charging infrastructure rises. With technological innovations and growing collaborations shaping the landscape, this sector is on track to transform how EVs integrate with energy systems. Let's explore the market size, key players, emerging trends, and segmentation details that define the future of DC wallbox chargers.
Steady Market…
Segment Analysis And Key Growth Categories In The Contrast Therapy Equipment Mar …
The contrast therapy equipment market is on track for significant expansion as demand for innovative recovery and rehabilitation solutions continues to rise. Driven by technological advancements and growing interest in health and fitness, this sector is expected to witness robust growth in the coming years. Below, we explore the market size, key players, emerging trends, and segment details shaping the landscape.
Projected Growth and Size of the Contrast Therapy Equipment Market
The…
More Releases for Therapeutics
Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | …
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years.
DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Adrenomyeloneuropathy, historical and forecasted epidemiology as well as the Adrenomyeloneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Discover about the Adrenomyeloneuropathy market report @ https://www.delveinsight.com/report-store/adrenomyeloneuropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Some of the…
Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme …
Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the upcoming years.
DelveInsight has launched a new report on "Pompe Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain,…
Dark Genome Therapeutics Market Deep Research Report with Forecast to 2032 | myN …
The qualitative latest Research report (2025-2032) on the Dark Genome Therapeutics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133611
Focused on growth…
Hodgkin's lymphoma Therapeutics Market Size Report 2032 | Affimed Therapeutics, …
DelveInsight's "Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hodgkin's Lymphoma, historical and forecasted epidemiology as well as the Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United kingdom and Japan.
Discover Key Insights into the Hodgkin's lymphoma Market with DelveInsight's In-Depth Report @ Hodgkin's lymphoma Market Size- https://www.delveinsight.com/sample-request/hodgkins-lymphoma-hl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Hodgkin's…
CRISPR Therapies Pipeline 2024 | Intellia Therapeutics, CRISPR therapeutics, Rep …
DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the CRISPR Therapies pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CRISPR Therapies therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive CRISPR Therapies pipeline products in this space.
Key Takeaways from…
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025.
North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant…
